A new study suggests that we can scale up production of poppy plants that produce a potent anti-cancer agent.
When it comes to complex medical decisions, cold hard statistics may hold little sway over patients in the face of a single, compelling anecdote.
A government panel finds there is little evidence that a common prostate-cancer screening saves men’s lives and instead raises the risk of unnecessary harm
Early detection of prostate cancer can mean survival rates of close to 100%.
An experimental treatment for prostate cancer tumors using high-intensity focused ultrasound (HIFU) shows promise as an effective treatment with fewer side effects than existing therapies.
Many people take a daily aspirin to reduce their risk of heart attack, but now fresh evidence suggests that the over-the-counter pain reliever may be a powerful tool in cancer prevention as well.
A new study expands the benefits of circumcision beyond protection from sexually transmitted diseases like HIV
Our risk of cancer rises dramatically as we age — cancer is, after all, a disease of aging, a consequence of our increasing longevity. So it makes sense that the elderly should be routinely screened for new tumors — or doesn’t it?
We’re back with three great topics this week: research showing dietary supplements are linked to a higher risk of early death; evidence that the internet might actually be useful in teaching teens healthy sexual behavior; and new …
Adding to the evidence that regularly taking dietary supplements may do more harm than good, researchers at the Cleveland Clinic have found that men taking vitamin E are not protected from prostate cancer, and may even be at …
A panel of cancer experts is recommending against testing for prostate-specific antigen (PSA), the most commonly used prostate cancer screen, in healthy men.
A new study seeks to predict the chances of sexual dysfunction in patients who are treated for prostate cancer — a key question for many men facing the disease.
Pop a Tylenol and take a brisk walk for protection against prostate cancer? That’s what the findings of two new studies published this week suggest.